跨越竞争丛林与范式重构:全球治理改革进程中的疫苗产业创新治理

Crossing the Jungle of Competition and Paradigm Reconfiguration:Innovative Governance of Vaccine Industry in Global Governance Reform

疫苗作为新冠疫情防控的最关键手段之一,已在各国抗疫中发挥积极影响。疫苗研发、生产、注射意愿以及全球分配的公平性与可及性等一系列问题日益受到世界关注。分析全球治理改革中,疫苗作为一种全球公共产品的创新治理问题,讨论疫苗产业发展特征与创新规律演化,剖析西方国家疫苗产业创新治理困境以及“竞争丛林”逻辑,阐释中国行动方案及对全球治理改革的贡献。最终提出疫苗产业创新治理机制对推动全球治理改革的政策含义。

Vaccines,as one of the most critical means of COVID-19 prevention and control,are already playing a positive role in countries'response to the epidemic.A series of issues such as vaccine R&D,production,willingness to inject,and equity and accessibility of global distribution become a big concern.This paper analyzes the innovative governance of vaccines as a global public good in the reform of global governance.The paper firstly discusses the regulation and characteristics of vaccine industry innovation governance.Then the paper analyzes the dilemma and competition jungle of vaccine industry innovation governance in western countries,as compared to China's action plan.From the angel of global public goods,the paper brings forward the policy implications of vaccine industry innovation governance mechanism in global governance reform.